Laborate Pharmaceuticals India Ltd.

Similar documents
Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

67 Years of Leadership in Pharmacy. A Journey of Continuous Improvement

300 3PORTUGUESE 65M GLOBAL WHO WE ARE WE OFFER PORTUGUESE

Eligibility List 2018

Annex 2 A. Regional profile: West Africa

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

High-Quality Delivery On Short Time Best Prices

Update on progress of MPP sublicensees

INDO-AFRICA PHARMA BUSINESS MEET

THE CARE WE PROMISE FACTS AND FIGURES 2017

about us Cyndea Pharma independent

What is this document and who is it for?

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

NO CHILD SHOULD DIE OF DIABETES

Prioritizing Emergency Polio Eradication Activities

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

Aboubacar Kampo Chief of Health UNICEF Nigeria

Impact Dashboard - October 2014

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Impact Dashboard - August 2014

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Procedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Comparative Analyses of Adolescent Nutrition Indicators

Sino implant (II) Increasing Access by Introducing a Low Cost Contraceptive Implant

Global Fund Results Fact Sheet Mid-2011

TT Procured by UNICEF

O c t o b e r 1 0,

MATERNAL, NEWBORN, AND CHILD HEALTH

Why is Medicine Quality Important?

מדינת ישראל. Tourist Visa Table

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

US Imports of Essential Oils, 2009 to 2013 Part One

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

PHARMA LIMITED (NIGERIA)

AIDS in Africa. An Update. Basil Reekie

Seizures of ATS (excluding ecstasy ), 2010

impact dashboard - august 2018

Providing affordable and innovative medicines for healthier lives. Q1 FY2016 Earnings Presentation August 2015

Tipping the dependency

impact dashboard - june 2018

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions

Market Updates: Routine Vaccine Introductions IPV. Vaccine Industry Consultation October 2018 UNICEF Supply Division

2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Pharmacovigilance BMGF Perspective. Raj Long Bill & Melinda Gates Foundation

February Health Impact Report 2010

Worldwide Regulatory Perspective on Herbal Drugs & Herbal formulations

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

Global Fund ARV Fact Sheet 1 st June, 2009

impact dashboard - september 2018

impact dashboard - may 2018

CND UNGASS FOLLOW UP

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

ANNEX 3: Country progress indicators

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

ICM: Trade-offs in the fight against HIV/AIDS

UNAIDS Office on AIDS, Security and Humanitarian Response; Initiative on HIV/AIDS and Uniformed Services, with special emphasis on young recruits

EFFERVESCENT in the 21st century

Global reductions in measles mortality and the risk of measles resurgence

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

impact dashboard year-end with 2017 coefficients

October 2011 Monthly Health Impact Report

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

Disparities in access: renewed focus on the underserved. Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014

Supplementary appendix

#TEAM45. Fundraising Guide

Financing malaria control

Medicines Regulation, Regulatory Harmonization, Global Initiatives. Tonya Villafana, PhD, MPH Senior Health Specialist, World Bank

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

We are a WHO GMP & ISO 9001:2000 certified company engaged in the Manufacturing and Exporting of Pharmaceutical Formulations. We are committed to

Why Invest in Nutrition?

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa

Expert Group Meeting on the Regional Report for the African Gender and Development Index

Global Fund Mid-2013 Results

UNAIDS 2013 AIDS by the numbers

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

Vaccine Banks. Susanne Munstermann, OIE Scientific and Technical Department

Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

What is Treatment Optimisation (TO)

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

HPV Vaccine Lessons Learned & New Ways Forward

Maternal Deaths Disproportionately High in Developing Countries

JOINT TB AND HIV PROGRAMMING

Post-2015 Development Agenda THE WORLD WE WANT

PROGRESS REPORT ON DECADE OF TRADITIONAL MEDICINE IN THE AFRICAN REGION. Progress Report. CONTENTS Paragraphs BACKGROUND PROGRESS MADE...

COMPANY PROFILE. AL SHAMS Group

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!

Transcription:

Laborate Pharmaceuticals India Ltd. About us: LABORATE is one of the fastest growing pharmaceutical company in India, since 1985 as manufacturers and exporters of pharmaceutical formulation. We are privileged to have been partners, physicians and chemist's trusted aide for over 29 years. Mission: Bring values to life with Quality Care Products at Affordable Price. To provide total customer satisfaction with speedy delivers at competitive prices with confidence of trust by maintain long term health relationship. Vision: To be a leading Generic Global Company in World Awards & Rewards: Laborate is honored with EMERGING INDIAN AWARD by ICICI and CNBC, 2008 UDYOG RATTAN AWARD EXCELLENCE AWARD by Institute of Economic Studies (IES), 2008 Achievements & Milestones: In 2007, IMS ORG ranked Laborate Pharmaceuticals amongst the top 50 pharmaceutical companies in India. Laborate Pharmaceuticals has crossed USD 100 Mn mark in year 20013 14, with export turnover of around USD 20 Mn. Manufacturing Facilities: We have three world class, State of the art manufacturing facilities approved by WHO GMP. These facilities are made as per the guidelines of US FDA and UK MHRA. Our multiple dosage form plants can manufacture several products at time and capable of handling high pressure, high temperature to low temperature (from 25 o C to 7 o C).

Locations: (1) Plant I: E 11, Industrial Area, Panipat, Haryana, India 132103 Dosage forms: Tablet; Capsules; Dry & Liqud Injectables; E/E Drops; Topical Preparations (2) Plant II: 51, Industrial Area, Paonta Sahib, Dist. Sirmour (H.P.) India 173025 Dosage forms: Tablet; Capsules; Dry & Liqud Injectables; E/E Drops; Topical Preparations (3) Plant III: 31, Rajban Road, Nariwala, Paonta Sahib, Dist. Sirmour (H.P) India, 173025 Dosage forms: Tablet; Capsules; Dry & Liqud Injectables; E/E Drops; Topical Preparations; Dry & Liquid Orals. Accreditation: We have WHO GMP certificated manufacturing Plants. Our world class, state of the art manufacturing facilities are approved by FDA of 15 countries. FDA Approvals: NAFDAC Nigeria Pharmacy and Poison Board Kenya MOH Yemen MOH Tajikistan MOH Bhutan CDDRA, Sri Lanka MOH Iraq FDB Ghana MOH Sierra Leone CAMEG, Togo CAMEBU, Burundi CAMERWA, Rwanda Government of India recognized Export House

Our Presences: In Indian Market: Laborate Pharmaceuticals India Ltd a leading name in Indian Pharmaceutical sector manufacturing a wide range of dosages form operates four successful divisions in domestic market. The Health Care, Life Science, Multicure and Zypher are four marketing division reaching different customer segments with an aim for achieving better coverage, customer satisfaction & cost effectiveness. These divisions ensure right quality of product available at the right price at right time. Laborate is having highly skilled field force of 300 people which makes our presence across all 35 states of India. We have strong distribution network through our 3 Depo, 8 C&F agents, 118 Distributors and 5072 Stockist. In International Market: Since 1989, Laborate has been exporting its products to Europe, U.K, South Africa, and Eastern Western African countries under its brand name with our products registered in more than 35 countries. We have established an international marketing network by virtue of quality our products, which are marketed worldwide. We have separate team for regulatory affairs who constantly work on preparations of all documents like products registration dossiers, stability testing, bioavailability and COPP of all drugs. The export division monitors the growing need of our customers worldwide & caters to their specific demands with efficiency and effectiveness. It is this philosophy which forms the backbone of our export division. We always focused our strategy towards doing things on time, to be able to adapt to customer's requirements and doing things in a cost effective manner. Our Products are registered in following countries: Asian Countries - Middle East Countries - Caribbean Countries - Sri Lanka Myanmar Afghanistan Nepal Thailand Bhutan Philippines Iraq Yemen Jordan Lebanon Syria West Indies Trinidad & Tobago Guatemala Costa Rica African Countries European Countries - CIS Countries - Nigeria Sierra Leone Burkina Faso Ghana Kenya Uganda Tanzania Benin Mozambique Guinée Burundi Rwanda Togo Ivory Coast Angola Mauritius Madagascar Liberia England Germany Netherlands Belgium Italy CHMP France Tajikistan Turkménistan Uzbekistan

Our Partners: International Partners: Laborate is having Marketing License Agreement with Leading Pharmaceutical Companies for Nigeria and Sri Lanka. We are one of the Preferred Supplier Status for World s Leading Institutions and Government Health Ministries. We are also the approved supplier to World Health Organization (WHO) Our products are procured across the world by some of the leading Ministry of Health & Health care organization like: CHMP France IMRES Netherlands Embassy pharma Nigeria CAMEC Burkina Faso SPC Sri Lanka MOH Mauritius CAMERWA Rwanda PNA Senegal CAMEBU Burundi FDA Nepal CAMEG Togo PSI Ivory Coast MOH Thailand PPB Kenya Quality Aspect: Quality control and quality assurance is an independent department which follows strict guidelines of quality control, quality assurance and in process control test. The testing of raw, packaging and finished materials is done by highly qualified technical staff with full specification and complete testing facilities.

Our all equipments operated under PLC (Programmable Logic Controller). We have in house quality checks, which are detailed in our SOP s and properly documented. Our State of the art in house testing facilities equipped with GC, FTIR, HPLC, UV and other latest techniques complying with International Pharmacopeial requirements. Quality Policy: We ensure that all recommendations of national and international regulations and guidelines are implemented timely and effectively practiced. It is our endeavor to bring delight to our internal and external customers through excellence and continuous improvement. Production Capacity: Laborate Pharmaceuticals offers sterile and non sterile products. We are engaged in the manufacturing of sterile injectables (Lyophilized & Non Lyophilized Injections). We can manufacture high value low volume to high volume finished formulations. We have exclusives dedicated blocks for β lactum and non β lactum antibiotics. Our current production on daily basis is about Liquid injections 200,000 vials & 300,000 ampoules. Ophthalmic 300,000 Dry Injections 300,000 Topical Preparations 200,000 tubes Tablets 15 Mn units Capsules 2 Mn units Dry Syp 100, 000 Bottles Liquid Preparations 100,000 (Syp/ Emulsions/ Susp) Product Range: We are amongst the few pharmaceutical companies in India which is having huge basket of finished formulations. Laborate is having 300+ products in its product portfolio which includes Antibiotics, Antifungal, Antipyretic, Anti inflammatory, Analgesics, (Steroids and NSAID s drugs), Antiulcerants, Multivitamins, Calcium and Iron supplements, Eye and Ear Drops, Cough and Cold remedies, Anti Asthmatic and Anti Histaminic, Dermatology, Cardio Diabetic, Gynecologist, ENT,

Ophthalmic Products. We also have products for Erectile Dysfunction, OTC, Neutracueticals and Ayurvedic Preparations. Our dosage form includes: Injectable: β Lactum and Non β Lactum Injectables Lyophilized (Dry) & Non Lyophilized (Liquid) Injections Infusions (100ml) Large Volume Parenterals Tablets: : β Lactum and Non β Lactum Capsules: : β Lactum and Non β Lactum Syrups and Suspensions: β Lactum and Non β Lactum Liquid Syrups and Suspension Dry Syrup Paediatric Drops Ophthalmic & ENT drops Topical Preparations Derma Range (Anti Acne / Antibiotics / Antifungal /Antiviral / Analgesics / Topical Steroids / Cosmetic Products) Topical Preparations for Erectile Dysfunction